New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 17, 2014
07:17 EDTMDCOThe Medicines Co. downgraded to Market Perform from Outperform at Leerink
Leerink downgraded The Medicines Co. to Market Perform citing uncertainty regarding Angiomax estimates into the appeals trial. The firm lowered its price target for shares to $27 from $30.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
06:14 EDTMDCOThe Medicines Co. to host investor and analyst meeting
Infectious Disease Care Investor and Analyst Meeting will be held on September 24 at 8:30 am. There will be a conference call hookup and webcast available. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use